Clinical symptoms and neutropenia: the balance of neutrophil development, functional activity, and cell death Taco W. Kuijpers Original Paper Pages: S75 - S82
Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1 Gepke VisserJan RakePeter G. Smit Original Paper Pages: S83 - S87
The muscle-bone relationship: methods and management – perspectives in glycogen storage disease Eckhard SchönauBernd SchwahnFrank Rauch Original Paper Pages: S50 - S52
Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence Gerhard DäublinBernd SchwahnUdo Wendel Original Paper Pages: S40 - S45
Disturbed lipid metabolism in glycogen storage disease type 1 Robert H. BandsmaPeter G. SmitFolkert Kuipers Original Paper Pages: S65 - S69
Contraception and pregnancy in women affected by glycogen storage diseases Valérie MairovitzPhilippe LabruneRené Frydman Original Paper Pages: S97 - S101
Consensus guidelines for management of glycogen storage disease type 1b – European Study on Glycogen Storage Disease Type 1 Gepke VisserJan RakePeter G. Smit Original Paper Pages: S120 - S123
Glycogen storage disease type I: indications for liver and/or kidney transplantation Philippe Labrune Original Paper Pages: S53 - S55
Association of glycogen storage disease 1b and Crohn disease: results of a North American survey Brian K. DieckgraefeJoshua R. KorzenikLisa Dieruf Original Paper Pages: S88 - S92
Glycogen storage disease type I: pathophysiology of liver adenomas Philip Lee Original Paper Pages: S46 - S49
Radical trapping in glycogen storage disease 1a Birgit WittensteinMarcus KleinAlfried Kohlschütter Original Paper Pages: S70 - S74
Enzyme therapy for Pompe disease: from science to industrial enterprise Arnold J. ReuserHannerieke Van den HoutAns T. Van der Ploeg Original Paper Pages: S106 - S111
Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease David A. WeinsteinJoseph I. Wolfsdorf Original Paper Pages: S35 - S39
Is glycogen storage disease 1a associated with atherosclerosis? Froukje L. UbelsJan RakeAndries J. Smit Original Paper Pages: S62 - S64
Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a Janice ChouAdriana ZingoneChi-Jiunn Pan Original Paper Pages: S56 - S61
Severe pulmonary arterial hypertension in type 1 glycogen storage disease Marc HumbertPhilippe LabruneGérald Simonneau Original Paper Pages: S93 - S96
Glycogen storage disease type I: diagnosis and phenotype/genotype correlation Dietrich MaternHans SeydewitzYuan-Tsong Chen Original Paper Pages: S10 - S19
Guidelines for management of glycogen storage disease type I – European Study on Glycogen Storage Disease Type I (ESGSD I) Jan RakeGepke VisserPeter G. Smit Original Paper Pages: S112 - S119
Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I) Jan RakeGepke VisserPeter G. Smit Original Paper Pages: S20 - S34
Historical highlights and unsolved problems in glycogen storage disease type 1 Shimon W. Moses Original Paper Pages: S2 - S9
